TerrAscend (TSNDF) Non-Current Debt (2020 - 2026)
TerrAscend (TSNDF) reported Non-Current Debt of $204.9 million for Q1 2026, up 11.83% year-over-year from $183.3 million in Q1 2025, and up 0.53% quarter-over-quarter from $203.8 million in Q4 2025.
TerrAscend (TSNDF) Non-Current Debt (2020 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 7 years of Non-Current Debt data on file, last reported at $204.9 million in Q1 2026.
- Non-Current Debt for Q1 2026 came in at $204.9 million, up 11.83% year-over-year; the trailing twelve-month figure through Mar 2026 was $204.9 million (up 11.83% YoY), and the FY2025 annual result was $203.8 million, up 11.11% from the prior year.
- Non-Current Debt grew to $204.9 million in Q1 2026 per TSNDF's latest filing, from $203.8 million in the prior quarter.
- Over five years, Non-Current Debt peaked at $247.6 million in Q3 2022 and troughed at $58.4 million in Q1 2024.
- A 5-year average of $180.7 million and a median of $183.5 million in 2024 frame the typical range for Non-Current Debt.
- The sharpest annual moves came in 2024 and 2025: Non-Current Debt plunged 60.04% in 2024, then soared 213.74% in 2025.
- A 5-year view of Non-Current Debt shows it stood at $145.9 million in 2022, then sank by 57.74% to $61.6 million in 2023, then surged by 197.67% to $183.5 million in 2024, then grew by 11.11% to $203.8 million in 2025, then climbed by 0.53% to $204.9 million in 2026.
- Business Quant data shows TSNDF's Non-Current Debt at $204.9 million in Q1 2026, $203.8 million in Q4 2025, and $211.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 14.02 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 9.05 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 3.92 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.48 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 569.60 Mn |
| 10 | TerrAscend | - | - | 34.60 Mn | 204.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 204.93 Mn |
| Mar 31, 2026 | 204.93 Mn |
| Dec 31, 2025 | 203.85 Mn |
| Dec 31, 2025 | 203.85 Mn |
| Sep 30, 2025 | 211.91 Mn |
| Sep 30, 2025 | 211.91 Mn |
| Jun 30, 2025 | 199.12 Mn |
| Jun 30, 2025 | 199.12 Mn |
| Mar 31, 2025 | 183.25 Mn |
| Mar 31, 2025 | 183.25 Mn |
| Dec 31, 2024 | 183.46 Mn |
| Dec 31, 2024 | 183.46 Mn |
| Sep 30, 2024 | 182.58 Mn |
| Sep 30, 2024 | 182.58 Mn |
| Jun 30, 2024 | 171.93 Mn |
| Jun 30, 2024 | 171.93 Mn |
| Mar 31, 2024 | 58.41 Mn |
| Mar 31, 2024 | 58.41 Mn |
| Dec 31, 2023 | 61.63 Mn |
| Dec 31, 2023 | 61.63 Mn |